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ARTICLE
Caspase-8 mediates inflammation and disease
in rodent malaria
Larissa M. N. Pereira1,2,3,7, Patrícia A. Assis 3,7, Natalia M. de Araújo1,2, Danielle F. Durso3, Caroline Junqueira1,
Marco Antônio Ataíde1,2, Dhelio B. Pereira 4, Egil Lien3, Katherine A. Fitzgerald3, Dario S. Zamboni 5,
Douglas T. Golenbock 1,3 & Ricardo T. Gazzinelli 1,2,3,6✉
Earlier studies indicate that either the canonical or non-canonical pathways of inflammasome
activation have a limited role on malaria pathogenesis. Here, we report that caspase-8 is a
central mediator of systemic inflammation, septic shock in the Plasmodium chabaudi-infected
mice and the P. berghei-induced experimental cerebral malaria (ECM). Importantly, our
results indicate that the combined deficiencies of caspases-8/1/11 or caspase-8/gasdermin-
D (GSDM-D) renders mice impaired to produce both TNFα and IL-1β and highly resistant to
lethality in these models, disclosing a complementary, but independent role of caspase-8 and
caspases-1/11/GSDM-D in the pathogenesis of malaria. Further, we find that monocytes from
malaria patients express active caspases-1, -4 and -8 suggesting that these inflammatory
caspases may also play a role in the pathogenesis of human disease.
https://doi.org/10.1038/s41467-020-18295-x OPEN
1 Instituto Rene Rachou, FIOCRUZ-MG, Belo Horizonte, MG 30190-002, Brazil. 2 Departamento de Bioquímica e Imunologia, ICB, Universidade Federal de
Minas Gerais, Belo Horizonte, MG 31270-901, Brazil. 3 Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
4 Centro de Pesquisas em Medicina Tropical, FIOCRUZ-RO, Porto Velho, RO 76812-329, Brazil. 5 Departamento de Biologia Celular Molecular e Bioagentes
Patogenicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP 14049-900, Brazil. 6 Plataforma de Medicina
Translacional, Fundação Oswaldo Cruz/Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, SP 14049-900, Brazil. 7These authors contributed equally:
Larissa M. N. Pereira, Patrícia A. Assis. ✉email: ricardo.gazzinelli@umassmed.edu
NATURE COMMUNICATIONS |         (2020) 11:4596 | https://doi.org/10.1038/s41467-020-18295-x | www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
Malaria is a major public health problem in >90 countries,and according to the World Health Organization affects>200 million people and kills over 400,000 children
each year. The rupture of parasitized red blood cells (RBCs)
release pathogen and danger-associated molecular patterns such
as DNA, RNA, hemozoin and glycosylphosphatidylinositol (GPI),
and uric acid1 that activate Toll-like receptors (TLRs)2,3, Nod-like
receptors (NLRs)4–7, and the cyclic GMP–AMP (cGAS) syn-
thase8. The activation of pattern-recognition receptors leads to
inflammatory priming and secretion of pyrogenic cytokines, such
as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNFα)
that are responsible for signs of disease, such as high fever, chills,
and rigors. Malaria priming also leads to an exquisite sensitivity
to secondary bacterial infection, in particular non-typhoidal sal-
monellosis, that often associates with severe disease9–12. Hence, a
better understanding of the mechanisms that arm the innate
immune cells to overreact during malaria is critical for the clinical
management and prevention of severe disease.
IL-1β processing and release are tightly controlled. After
translation, a pro-IL-1β inactive protein is cleaved by caspase-1
that is activated in an inflammasome-dependent process13.
Inflammasomes are multiprotein complexes assembled by the
oligomerization of NLRs and AIM2. The activation of caspase-1
requires an inflammasome assembly that is under the control of
two signaling checkpoints. First, TLR signaling leads to enhanced
transcription of inflammasome components, pro-caspase-1 and
pro-IL-1β genes14,15. Then, a second signal triggered by NLRs or
AIM2 activation promotes inflammasome assembly16. This sec-
ond signal is induced by many stimuli, including DNA for AIM2,
urate crystal, ATP, oxygen reactive, as well as microbial infections
that activate NLRP316,17.
When challenged in vitro with hemozoin, monocytes release
IL-1β dependent on inflammasome and caspase-1 activation4,5.
Importantly, it was demonstrated that hemozoin binds to P.
falciparum nucleic acids and traffics into the lysosomal com-
partment and the cytosol of host cells, where parasite DNA
activates TLR96. Furthermore, it was demonstrated that mono-
cytes from febrile malaria patients express high levels of NLRP3,
NLRP12, and AIM2 inflammasome specks, as well as active
caspase-118,19. While experimental cerebral malaria (ECM)
develops in an inflammasome-independent manner, caspase-1
activation mediates hypersensitivity to endotoxin or super-
infection with Salmonella typhimurium, and this is attenuated in
P. chabaudi-infected NLRP3, NLRP12, or ASC knockout mice18.
A noncanonical inflammasome pathway that regulates IL-1β
production was also described20,21. Caspase-11 in mice and the
homolog caspase-4 in humans lead to the processing of pro-IL-1β
and promotes the pyroptosis by gasdermin-D (GSDM-D) clea-
vage, independent of inflammasome activation22,23. The N-
terminal product of GSDM-D binds to lipid and oligomerizes
in cell membranes to form pores24. Then, these pores promote
Ca2+ unbalance, the pyroptosis, and IL-1β release, as a
consequence25,26. Yet another member of this family of proteases
that plays an essential role in programmed cell death, caspase-8,
has recently been shown to promote NF-κB activation and induce
the synthesis of pro-IL-1β27–29. The role of Caspase-8 on IL-1β
release seems to be more complex as it is also involved in GSDM-
D cleavage30. However, their role in malaria pathogenesis has not
been addressed.
Here, we demonstrate that in vivo Plasmodium infection is
sufficient to activate caspases-11 (or caspase-4) and 8, both in
Plasmodium-infected mice and malaria patients. Our awards
indicate that while caspase-11 is dispensable, both caspase-1 and
caspase-8 are important mediators of IL-1β and TNFα secretion,
hypersensitivity to septic shock as well as the development
of ECM.
Results
Expression and activation of caspase-11 in P. chabaudi infec-
tion. Plasmodium infection induces pro-inflammatory priming
leading to hypersusceptibility to septic shock. To study the
importance of this pro-inflammatory priming on malaria
pathogenesis, we used a low-dose Lipopolysaccharide (LPS)
challenge in Pc-infected mice18,31,32. Previous studies demon-
strate that in Gram-negative bacterial infection, caspase-11 is
involved in caspase-1 activation upstream of inflammasome21.
The immunoblot using splenocytes reveals that pro-caspase-11
(p43 and p38 subunits) is induced in Pc-infected C57BL/6 mice.
The cleaved subunit of caspase-11 (p30) was found in the sple-
nocyte supernatants. As expected, we did not find caspase-11 in
samples from 129S6 (caspase-11 mutant mice), Casp11−/−, and
Casp1/11−/− mice (Fig. 1a). Splenocytes from Casp1−/−/11tg mice
showed regular induction and activation of caspase-11, indicating
that cleavage of caspase-11 does not require caspase-1 (Fig. 1b).
We also performed an immunoblot developed with an anti-
caspase-1 antibody in splenocyte lysates from Casp11−/− mice.
We found the p35 caspase-1 subunit in splenocytes from Pc-
infected mice, indicating that caspase-1 is cleaved by a caspase-
11-independent mechanism (Fig. 1c)33.
Expression of caspase-11 is dependent on IFNγ and NAS-TLRs.
Different studies also demonstrate that pro-caspase-11 is induced
by Type I IFN as well as TLR agonists, such as LPS, Poly IC, or
PAMCys334–37. Priming with TLR agonists or IFNs induces pro-
caspase-11 expression, but require a second challenge with LPS to
activate caspase-11. In these models, LPS-induced lethality does
not require Toll-like receptor 4 (TLR4)34,35. We found that the
induction of pro-caspase-11 and cleavage of p30 caspase-11
subunit in splenocytes from Pc-infected was independent of TLR4
(Supplementary Fig. 1a). However, the high levels of circulating
IL-1β and IL-1β produced by splenocytes from infected Tlr4−/−
mice stimulated with LPS were very low when compared to
infected C57BL/6 mice (Supplementary Fig. 1b). When we eval-
uated splenic CD11b+ cells from infected Tlr4−/− mice chal-
lenged with LPS, we observed lower intracellular levels of pro-IL-
1β in Tlr4−/− than in C57BL/6 mice (Supplementary Fig. 1c).
Furthermore, infected Tlr4−/− mice were resistant to LPS chal-
lenge (Supplementary Fig. 1d).
Plasmodium is a potent activator of TLR7, TLR9, and other
cytosolic receptors that sense nucleic acids2,6,31,38–40. In addition,
IFN-priming of innate immune cells is a hallmark of both human
and murine malaria32,39,40. Hence, we investigated the levels of
caspase-11 in mice lacking functional NAS-TLRs, IFNγ (Ifng), or
IFNα/β receptor (Ifnar1) genes. Consistent with previous
studies35–37,41, we found that both IFNγ and Type I IFNs are
key cytokine-priming differentiated monocytes for caspase-11
expression. The results presented in Supplementary Fig. 2a show
that in vitro, IFNγ, and IFN Type I are sufficient to induce
caspase-11 expression, and that caspase-11 p30 subunit is only
detected when bone marrow-derived macrophages (BMDMs)
were stimulated with iRBC. Expression of caspase-11 and its
active form was not affected in total splenocytes from single Tlr3-,
Tlr7-, and Tlr9-deficient mice infected with Pc (Supplementary
Fig. 2b–d). Nevertheless, we found that the expression of pro-
caspase-11 was highly impaired in splenocytes from Pc-infected
Tlr3/7/9−/−, Ifng−/−, or Ifnar1−/− mice (Fig. 1d). Expression of
pro-caspase-1 was not impaired, whereas cleavage and generation
of active caspase-1 were affected in total splenocytes from Pc-
infected Ifng−/−, but not Ifnar1−/− mice (Fig. 1e).
Caspase-1 has a dominant role in mediating IL-1β release in Pc
infection. A high proportion of circulating monocytes become
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activated during malaria18,42,43. In rodent malaria, most splenic
monocytes differentiate into inflammatory monocytes (iMOs,
CD11b+F4/80+CD11c−MHC II−), and monocyte-derived den-
dritic cells (MO-DCs, CD11b+F4/80+CD11c+MHC II+)44 and
the differentiated cells are the main source of active caspase-1 and
IL-1β at 8 days post infection with Pc18. To investigate whether
expression of pro-IL-1β is affected in Casp11−/− or Casp1/11−/−
mice, we performed intracellular staining for IL-1β in iMOs and
MO-DCs from spleens of control and Pc-infected mice, before
and 2 h after LPS challenge (Supplementary Fig. 3 and Fig. 2a).
We found the similar intensity of fluorescence of IL-1β in cells
from either infected C57BL/6, Casp11−/−, or Casp1/11−/− mice.
We then accessed the role of caspase-11 on IL-1β. Lower levels of
IL-1β were found in culture supernatants of LPS-stimulated
splenocytes from infected Casp11−/− mice when compared to
infected C57BL/6 mice. However, the IL-1β levels in splenocytes
from Casp11−/− were significantly higher than those from
Casp1−/−/11tg or Casp1/11−/− mice (Fig. 2b). In addition, when
compared to infected C57BL/6 mice challenged with a low dose of
LPS, lower levels of circulating IL-1β were observed in the plasma
of infected Casp1/11−/−, but not from Casp11−/− mice (Fig. 2c).
Hence, the Casp1−/−/11tg phenocopied the Casp1/11−/− and
not the Casp11−/− mice infected with Pc. The plasma IL-1β levels
in both control and infected mice not challenged with LPS
were below the limit of detection. Altogether, our results suggest
that in Pc-infected mice challenged with low-dose LPS, the
canonical pathway of caspase-1 activation has the predominant
role in IL-1β release. Consistently, deficiency of caspase-1 and not
caspase-11 resulted in a small, but the significant increment of
resistance to the low-dose LPS challenge in Pc-primed mice
(Fig. 2d). Furthermore, opposite to Ifng−/− mice24, the Ifnar1−/−
mice that are defective on caspase-11, but not on caspase-1
expression, were still highly susceptible to the low-dose LPS
challenge (Fig. 2e).
GSDM-D is cleaved by caspase-11 and caspase-1, generating
the p30 polypeptide, which polymerizes and forms pores in the
cell surface membrane of activated monocyte/macrophages. The
GSDM-D pores allow the release of IL-1β and also lead to
pyroptosis22–24,45. Consistent with the hypothesis of a dominant
role of the canonical pathway of caspase-1 activation, Pc-infected
Gsdmd−/− mice phenocopied the Casp1−/− rather than
Casp11−/− mice. Despite the severe impairment of IL-1β release
(Fig. 2f), as observed in the Casp1/11−/− and Casp1−/− mice, the
Gsdmd−/− mice were only partially resistant to the low-dose LPS
challenge (Fig. 2g).
Caspase-8 mediates IL-1β release in Pc-infected mice. The
Casp8−/− mice are not viable, but the viability is rescued in the
double Ripk3−/−/Casp8−/− mice, suggesting that unregulated
necroptosis is the main cause of embryonic lethality in the
caspase-8-deficient mice. Therefore, we used Ripk3−/− mice as
controls. The results are shown in Fig. 3a (top panel) indicate that
in vivo Pc infection leads to pro-caspase-8 expression (p55) and
cleavage of caspase-8 (p18) in monocytes. These results were
confirmed using a different anti-caspase-8 antibody that recog-
nizes caspase-8 p43- and p18-cleaved polypeptides in CD11b+
cells Fig. 3a (bottom panel). The cleavage of caspase-8 was
independent of both caspase-1 and caspase-11. In addition, our
results show that caspase-8 is not necessary for cleavage of either
caspase-1 or caspase-11 (Fig. 3b–d). Consistently, cleavage of
caspase-8 was unimpaired in Ifng−/− mice infected with Pc
(Fig. 3e), which are defective on caspase-1 cleavage and caspase-
11 expression.
Caspase-8 mediates TNFα-induced cell death and also
promotes NF-κB activation and production of pro-
inflammatory cytokines46, including TNFα28,29, which is an
important biomarker of severe malaria47,48. To evaluate the
importance of TNFα on caspase-8 activation, we used mice
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Fig. 1 Caspase-11 activation in P. chabaudi-infected mice. All results presented in this figure were obtained from mice either uninfected or at 8 days after
infection with Pc, as indicated. a, b Splenocyte lysates and supernatants were obtained from C57BL/6, 129S6, Casp11−/−, Casp1/11−/−, and Casp1−/−/11tg
mice, and analyzed by western blot using an anti-caspase-11 antibody. c Splenocyte lysates from C57BL/6, Casp11−/−, and Casp1/11−/− mice were analyzed
by western blot using an anti-caspase-1 antibody. d Splenocyte lysates obtained from C57BL/6, Tlr3/7/9−/−, Ifng−/−, and Ifnar−/− mice were analyzed by
western blot using an anti-caspase-11 antibody. e Splenocyte lysates were obtained from C57BL/6, Ifng−/−, and Ifnar−/− mice and analyzed by western
blot using an anti-caspase-1 antibody. Blots developed with an anti-β-actin were used as loading controls. All blots are representative of two to three
different experiments with similar results.
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deficient in the TNFp55 receptor gene Tnfrsf1a (here identified as
Tnfr−/−). Our results show that cleavage of caspase-8 was not
observed in lysates from CD11b+ cells derived from the spleen of
Pc-infected Tnfr−/− mice (Fig. 3f). In contrast, expression and
cleavage of either of caspase-1 or caspase-11 were not affected
(Fig. 3f).
The results presented in Fig. 4a show that the levels of
circulating IL-1β on Ripk3−/−/Casp8−/− or Ripk3−/−/
Casp8/1/11−/− mice are very low when compared to C57BL/6
mice infected with Pc and challenged with low-dose LPS.
Likewise, IL-1β release by splenocytes (Fig. 4b) and pro-IL-1β
expression by CD11b+/F4/80+ iMOs/MO-DC populations
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Fig. 2 Caspase-1-dependent release of IL-1β in Pc-infected mice challenged with LPS. a Splenocytes were stimulated with 1 μg/mL of LPS and used for
intracellular pro-IL-1β staining by flow cytometry. The pro-IL-1βMFI quantification was assayed in live (live/dead−) monocytes (CD11b+F4/80+, left panel)
and dendritic cells (CD11c+MHC II+, right panel). For MOs: C57BL/6 n= 9, Casp1/11−/− (control n= 5, + LPS n= 4; infected n= 6), and Casp11−/−
(control n= 6, +LPS n= 8; infected n= 7, +LPS n= 8). For monocyte-derived dendritic cells (MO-DCs): C57BL/6 n= 9, Casp1/11−/− (control n= 7, +LPS
n= 4; infected n= 9, +LPS n= 6), and Casp11−/− (control n= 6, +LPS n= 8; infected n= 7, + LPS n= 8). b Splenocytes were stimulated in vitro with
1 μg/ml of LPS and 24 h later IL-1β measured by ELISA in supernatants. Left panel: C57BL/6 (control n= 5, infected n= 6) and Casp1/11−/− n= 5. Right
panel: n= 3. c Mice were inoculated intravenously with 10 μg/mice of LPS, and 8 h later, plasma was collected and circulating IL-1β measured by ELISA.
Left panel: C57BL/6 (non-challenged n= 6, LPS-challenged n= 5) and Casp1/11−/− (non-challenged n= 5, LPS-challenged n= 3). Right panel: n= 3 for all
groups, except Casp1−/−/11tg (infected n= 2; infected +LPS n= 4). d C57BL/6, Casp11−/−, Casp1/11−/− (top panel), as well as C57BL/6 and Casp1−/−
(bottom panel) were inoculated intravenously with 10 μg/mouse of LPS, and survival followed for 72 h. e C57BL/6, Ifng−/−, and Ifnar−/− were inoculated
intravenously with 10 μg/mouse of LPS and survival followed for 72 h. f, left panel: Splenocytes were stimulated in vitro with LPS (1 μg/ml) and IL-1β
measured by ELISA in 24 h supernatants. For all groups, n= 3. f, right panel: C57BL/6 and Gsdmd−/− mice were inoculated i.v. with 10 μg/mouse of LPS
and plasma collected to measure the levels of IL-1β at 8 h post-challenge. C57BL/6 (n= 9, except infected +LPS n= 7) and Gsdmd−/− (control n= 2 and
control +LPS n= 7; infected n= 3 and infected +LPS n= 8). g C57BL/6 and Gsdmd−/− mice were challenged with 10 μg/mouse of LPS and followed for
survival. In a, b, c, and f, mean ± s.e.m of two-three different experiments are shown; statistical analysis by parametric or nonparametric t test and one-way
ANOVA. Survival curves were analyzed by log-rank test.
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(Fig. 4c) from both Pc-infected Ripk3−/−/Casp8−/− and
Ripk3−/−/Casp8/1/11−/− mice were impaired. As observed for
IL-1β, TNFα production by splenocytes from Pc-infected mice
was impaired in mice with various gene deficiencies (Fig. 4d).
Consistently, the release of IL-1β was highly impaired in Pc-
infected Tnfr−/− mice, which are also resistant to LPS challenge
(Supplementary Fig. 4a, b). Importantly, while the Pc-infected
Ripk3−/−/Casp8−/− mice were only partially resistant,
the infected Ripk3−/−/Casp8/1/11−/− and Ripk3−/−/Casp8/
Gsdmd−/− mice were highly resistant to the low-dose LPS-
induced lethality (Fig. 4e). The results obtained from Ripk3
single-knockout mice were identical to C57BL6, showing that
the deletion of this gene did not contribute to the phenotype
observed in the double Ripk3−/−/Casp8−/− or the quadruple
Ripk3−/−/Casp8/1/11−/−-deficient mice. These results also indi-
cate a loop of amplification that involves TNFα induction by
Pro-Casp-8 p55
Casp-8 p18
Actin
Casp-8 p18
Casp-8 p43
Actin
Casp-1 p20
Casp-1 p35
Pro-Casp-1 p50
Pro-Casp-8 p55
Casp-8 p43
Casp-8 p18
Actin
Pro-Casp-8 p55
Casp-8 p18
Pro-Casp-1 p50
Casp-1 p35
Casp-11 p30
Casp-11 p30
Casp-1 p20
Casp-1 p35
Pro-Casp-1 p50
Casp-1 p20
Pro-Casp-11 p43/p38
Actin
Pro-Casp-11 p43/p38
Pro-Casp-11 p43/p38
Actin
Actin
Actin
C57BL/6
a
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
C
D
11
b+
 ly
sa
te
s
Casp1/11–/–
C57BL/6
C57BL/6
Casp1/11–/– Ripk3–/–/Casp8–/–
Ripk3–/–/Casp8–/–
C57BL/6 Ripk3–/–/Casp8–/–
C57BL/6 Ripk3–/–/Casp8/1/11–/–
C57BL/6 lfng
–/–
C57BL/6
Splenocyte supernatant
Splenocyte supernatant
Tnfr–/–
– – – –++ + +Pc
– + + + +–+ + +Pc
– + + + +– +Pc
– + + + +– +Pc
– + + + +– +Pc
– + + +–Pc
– + + +–Pc
–– + + – +– +Pc
– –– + + + +– – – ++Pc
b
c d
e f
Fig. 3 Caspase-8 activation in Pc-infected mice. All results presented in this figure were obtained from mice either uninfected or at 8 days after infection
with Pc. C57BL/6, Casp1/11−/−, Ripk3−/−/Casp8−/−, Ripk3−/−/Casp8/1/11−/−, Ifng−/−, and Tnfr−/− mice were used in different experiments, as indicated.
CD11b+ cells purified from splenocytes were lysed in RIPA buffer to prepare the lysates. Alternatively, splenocytes were spin down 400 × g for 5 min to
prepare supernatants. Lysates from CD11b+ cells isolated from spleens of control and Pc-infected mice were analyzed by western blot using either a two
distinct anti-caspase-8; b anti-caspase-1 and anti-caspase-11; c anti-caspase-1; d anti-caspase-11; and e anti-caspase-8 antibodies. b, d Alternatively,
splenocytes supernatants were used to detect active caspase-11 (p30) by western blot using an anti-caspase-11 antibody. f Lysates of CD11b+ cells from
uninfected and infected C57BL/6 and Tnfr−/− mice were analyzed by western blot with anti-caspase-8, anti-caspase-1, and anti-caspase-11 antibodies.
Blots revealed with anti-β-actin were used as loading controls. Blots are representative of two to three different experiments with similar results.
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caspase-8, TNFα-induced caspase-8 cleavage, and consequent
activation of IL-1β. Hence, our results indicate that the
deleterious role of caspase-8 in the hypersensitivity to septic
shock in this malaria model may also involve the induction of
TNFα expression.
A neuroinflammation gene signature in MO-DCs from PbA-
infected mice. In our earlier studies, we found that MO-DCs are
an important source of active caspase-1, IL-1β and have a
pathogenic role in ECM and acute respiratory distress syndrome
in malaria (MA-ARDS) models18,44,49. To address the importance
of inflammatory caspases in ECM, RNA was extracted from MO-
DCs (CD11b+F4/80+CD11c+DC-Sign+MHC II+, purity >97%)
highly purified from spleens of control and infected mice (Sup-
plementary Fig. 3). The MO-DCs were purified at day 5 post
infection, since in this model, mice become very sick by days 6–7
post infection. The bar graph presented in Fig. 5a shows the main
inflammatory pathways that were enriched in MO-DCs from
PbA-infected mice. We found that three pathways were highly
relevant to our study, i.e., maturation of dendritic cells, neu-
roinflammation signaling, and NFκB signaling, which is pro-
moted by caspase-8. Importantly, the connectivity diagram shows
that both TNFα and IL-1β genes were involved in all three
pathways (Fig. 5b). In addition, we found that caspase-1, caspase-
11, and caspase-8 genes were all upregulated in splenic MO-DCs
from PbA-infected mice (Fig. 5c).
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Caspase-8 mediates P. berghei ANKA (PbA)-induced ECM.
Different studies have shown that double Casp1/11−/− mice are
still highly susceptible to ECM induced by PbA infection50,51. In
contrast, we found that caspase-8 contributes to the development
of ECM. Consistent, with the gene expression analysis, our
ex vivo results show that splenic CD11b+ cells from PbA-infected
mice express high levels of pro- and active caspases-1, -11
(Fig. 6a), and -8 (Fig. 6b) proteins. Consistent with the results
obtained with Pc-infected mice, we found that IL-1β and TNFα
produced by splenocytes stimulated with LPS were impaired
both in PbA-infected Ripk3−/−/Casp8−/− and Ripk3−/−/Casp8/1/
11−/− mice (Fig. 6c). Importantly, we observed a delay lethality of
Ripk3−/−/Casp8−/− infected with PbA, whereas Ripk3−/−/Casp8/
1/11−/− and Ripk3−/−/Casp8−/−/Gsdmd−/− mice were highly
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resistant to ECM (Fig. 6d). In contrast, Ripk3−/−, Gsdmd−/−, or
Casp1/11−/− mice were as susceptible to ECM as the C57BL/6
mice. The clinical signs of disease correlated with the lethality
curves (Fig. 6e). The images presented in Fig. 6f show the Evans
blue staining of C57BL/6 mice, but not Ripk3−/−/Casp8−/− or
Ripk3−/−/Casp8/1/11−/− infected with PbA. Pro-inflammatory
cytokines are known to promote blood–brain barrier perme-
ability, leading to leak and infiltration of mononuclear cells
contributing to ECM. Hence, these results are consistent with the
hypothesis that the defective cytokine response is contributing to
Casp8 knockout mice resistance to ECM. However, consistent
with the results from Pc-primed mice, caspase-8 also has an
important role in mediating ECM, which seems to be indepen-
dent of GSDM-D cleavage and IL-1β release. These results indi-
cate that caspase-8 and caspase-1 and -11 also have a
complementary role in the pathogenesis of ECM.
Expression of caspases-4 and -8 in monocytes from malaria
patients. Our previous studies show that infection with either P.
vivax or P. falciparum prime circulating monocytes to express an
inflammasome gene signature, form AIM2, NLRP3, and
NLRP12 specks, express active caspase-1, and produce high levels
of IL-1β, when challenged with LPS18,19,32. We now evaluated the
expression and activation of the inflammatory caspases-4 and -8
as well as GSDM-D in monocytes from malaria patients. It is well
established that cytokinemia and fever coincide with the syn-
chronized burst of infected red blood cells and the consequent
release of parasites1. Hence, blood samples from febrile malaria
patients were collected for peripheral blood mononuclear cells
(PBMC) isolation. Western blots of monocytes purified of
PBMCs from P. vivax-infected patients showed active caspase-4
(p32 subunit) (Fig. 7a). In addition, infection with P. vivax
induced expression and cleavage of caspase-8 in circulating
CD14+ monocytes (Fig. 7b). Furthermore, we found that GSDM-
D is cleaved in monocytes from P. vivax-infected individuals, and
not in monocytes from HD (Fig. 7c). A similar pattern of cas-
pase--8, GSDM-D and caspase-4 activation was observed in
monocytes from P. falciparum-infected patients (Fig. 7d, e).
Altogether, we provide evidence that P. vivax and P. falciparum
infection leads to induction and activation of caspases-4 and -8 as
well as GSDM-D in monocytes, which may contribute to the
overall amount of IL-1β and pathogenesis of malaria.
Discussion
Plasmodium infection results in activation of NLRs, inflamma-
some oligomerization, and caspase-1 via the canonical pathway in
circulating and splenic monocytes. Upon secondary stimuli, these
armed cells produce extremely high levels of IL-1β, which is
thought to be a key cytokine-mediating high peak of fever as well
as high sensitivity to endotoxic shock induced in bacterial
superinfection4–6,18,19. However, the role of caspase-11 and the
noncanonical inflammasome activation21 has not been taken into
consideration. Furthermore, different studies demonstrate the
role of caspase-8 on IL-1β synthesis and host cell death in bac-
terial and fungal infections27–30. Here, we report that caspase-11
and the homologous inflammatory human caspase-4, as well as
caspase-8, are highly activated during Plasmodium infection, both
in mouse and malaria patients. We found that while caspase-11
has a limited role, caspase-8 is essential for IL-1β release and to
mediate hypersensitivity to septic shock and cerebral disease in
ECM model.
Catalyzing the formation of β-hematin crystals (hemozoin) is a
key strategy to detoxify the heme released from hemoglobin
digestion by Plasmodium parasites52. Different studies have
reported that phagocytosis of hemozoin results in caspase-1
activation and IL-1β secretion by monocytes/macrophages, and
that this process is dependent on AIM2, NLRP3, and ASC oli-
gomerization4–6. Indeed, it was found that DNA bound to
hemozoin is essential to this process by activating TLR9 and
inducing expression of inflammasome components as well as pro-
IL-1β, whereas hemozoin crystals translocate to the cytoplasm of
phagocytic cells and promote inflammasome assembling6. In
addition, studies performed in our laboratory19 and elsewhere53
have shown that immunocomplexes-containing DNA present in
plasma of malaria patients as well as opsonized infected RBCs
also trigger the formation of inflammasome specks in human
monocytes. However, most of the early studies that evaluated the
role inflammasome in rodent malaria used a mouse strain that is
double deficient for caspase-1 and caspase-11. Importantly, it was
found in other infectious disease models that caspase-11 is
involved in induction of pyroptosis, alarmin as well as IL-1β
secretion, in a process that is independent of the canonical acti-
vation of inflammasome21,54,55. Hence, we revisited this question
to evaluate the contribution of the noncanonical pathway on IL-
1β release during malaria.
The inflammasome activation through the noncanonical
pathway requires as starting point caspase-11 activation in the
mouse. Once activated, these inflammatory caspases are thought
to promote potassium efflux, NLRP3, and ASC oligomerization
and consequently, caspase-1 activation that amplifies cleavage of
pro-IL-1β56–58. Different studies also demonstrate that pro-
caspase-11 is induced by Type I IFN as well as TLR agonists,
such as LPS, Poly IC, or PAMCys334–37. Recent studies have
demonstrated that, like caspase-11, cytosolic LPS is an agonist
for the noncanonical inflammasome in humans and revealed
that the inflammatory caspase-4 is a direct sensor of bacterial
endotoxin22,57,59.
We also found that in vivo Plasmodium infection was sufficient
to activate caspase-11 in mice. As TLRs have been shown
necessary in the process of priming for induction of pro-caspase-
11 and TLR7 as well as TLR9 are strongly activated by infection
with malaria parasites31,60,61, we investigated the role of NAS-
TLRs on activation of the noncanonical inflammasome pathway.
Importantly, activation of NAS-TLRs during malaria is important
to trigger IL-12, which is necessary for maximal IFNγ response
during acute infection with malaria31,32,44,62. We found that
expression of pro-caspase-11 was diminished both in triple Tlr3/
7/9 as well as Ifng knockout mice infected with P. chabaudi.
Importantly, our in vitro experiments indicate that whereas IFNγ
is required to induce pro-caspase-11, activation with infected
erythrocytes promoted cleavage of pro-caspase-11. Indeed, it has
been demonstrated that a combined activation by NAS-TLRs and
IFNγ results in high expression of pro-caspase-11 in the host cell
cytoplasm41, which initiates the process of self-cleavage63.
It has also been shown that caspase-11 needs a secondary sti-
mulus with cytosolic LPS to be activated and promote endotoxic
shock in a process independent of TLR434,35. It is established that
LPS binds to the caspase-11 CARD domain and is required to
promote caspase-11 activation. However, our in vivo and ex vivo
experiments indicate that caspase-11 was not necessary to cleave
caspase-1 and had a limited role in secretion of IL-1β or sus-
ceptibility to the low-dose LPS-induced shock. Different from the
bacteria models described above, Plasmodium infection was suf-
ficient to induce and activate caspase-11, and TLR4 was required
to induce pro-IL-1β, the release of IL-1β, and lethality induced by
LPS challenge.
In addition to caspase-1 and caspase-11, caspase-8 has also
been shown to play a key role in regulating IL-1β secretion in
bacterial and fungal infections27–29. These studies indicate that
caspase-8 mediates the synthesis of pro-IL-1β by activating NF-
κB. Unlike caspases-1 and -11, the role of caspase-8 does not
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18295-x ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4596 | https://doi.org/10.1038/s41467-020-18295-x | www.nature.com/naturecommunications 9
seem to be IL-1β specific, since its deficiency also impairs the
synthesis of other cytokines, such as TNFα and IL-646. Con-
sistently, we found that the release of both IL-1β and TNFα was
highly impaired in the caspase-8-deficient mice infected with Pc
or PbA.
Caspase-8 was also shown to be involved in GSDM-D clea-
vage30. However, in our experiments, caspase-8 was not required
for caspase-1 or caspase-11 cleavage. Importantly, the Pc-infected
Gsdmd−/− phenocopied the Casp1−/− mice, which were slightly
more resistant to the LPS-induced shock. Intriguingly, Plasmo-
dium-infected Gsdmd−/− mice showed severe impairment of IL-
1β release, but remained susceptible to the low-dose LPS chal-
lenge or ECM. Therefore, the lethality in these models cannot be
explained solely based on cleavage and release of IL-1β. Fur-
thermore, either Casp1/11−/− 50,51 or Gsdmd−/− mice were
highly susceptible to ECM. Nevertheless, like Ripk3−/−/Casp8/1/
11−/−, the Ripk3−/−/Casp8−/−/Gsdmd−/− mice were highly
resistant to ECM. Together, these results indicate that while
redundant in these malaria models, the role of caspase-8 is
complementary but distinct from the canonical inflammasome
that involves caspases-1 and GSDM-D activation.
Infection with P. vivax elicits high fever and paroxysm thought
to be dependent on IL-1β, whereas P. falciparum infection is the
most lethal species and the cause of cerebral malaria in humans,
which is dependent on TNFα47. Hence, we evaluated whether
inflammatory caspases and GSDM-D are activated in monocytes
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with an anti-caspase-4 antibody. The levels of caspase-4 p32 expression were analyzed by densitometry and shown in the bottom panel (HD n= 7 and P.
vivax n= 8). b Western blot was performed with CD14+ monocytes lysates from two HD and five P. vivax malaria patients, and expression of caspase-8
(p55) and cleaved caspase-8 (p18) detected using an anti-caspase-8 antibody. The levels of caspase-8 p18 expression were analyzed by densitometry and
shown in the bottom panel (HD n= 4 and P. vivax n= 9). cWestern blot was performed with CD14+ monocytes lysates from HD as well as P. vivaxmalaria
patients and revealed with an anti-GSDM-D antibody. The levels of cleaved GSDM-D p30 expression were analyzed by densitometry and shown in the
bottom panel (HD n= 7 and P. vivax n= 9). d CD14+monocytes lysate isolated from healthy donors (HD) and malaria patients (P. falciparum) were
analyzed by western blot performed against caspase-8 and GSDM-D. The levels of caspase-8 and GSDM-D expression were analyzed by densitometry and
shown in the side panels (HD n= 3 and P. falciparum n= 6). e CD14+monocytes lysate isolated from healthy donors (HD) and malaria patients (P.
falciparum) were analyzed by western blot performed against caspase-4. The levels of caspase-4 expression were analyzed by densitometry and shown in
the bottom panel (HD n= 4 and P. falciparum n= 5). Statistical analysis was performed by two-tailed unpaired Mann–Whitney test at 95% CI.
Densitometry graphs show mean ± s.e.m of samples from patients run on two to three representative gels with similar results.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18295-x
10 NATURE COMMUNICATIONS |         (2020) 11:4596 | https://doi.org/10.1038/s41467-020-18295-x | www.nature.com/naturecommunications
from malaria patients. We have previously shown that AIM2 and
NLRP3 inflammasomes, as well as caspase-1, are activated in
monocytes from malaria patients18. Here, we found that in vivo
infection with either P. vivax or P. falciparum is sufficient to
activate caspase-4 and cleave GSDM-D in monocytes without
exposure to LPS. In addition, we found that monocytes from
patients infected with Plasmodium spp. process caspase-8, indi-
cating their potential role in IL-1β release and pathogenesis of
malaria.
In conclusion, our results demonstrate that caspase-1, caspase-
8, the mouse caspase-11, and its human ortholog caspase-4 are all
activated in monocytes from P. vivax and P. falciparum malaria
patients and mouse malaria models. The important role of the
canonical activation of the inflammasome is revealed in caspase-
8-deficient mice. While redundant, our data indicate that in these
malaria models the mechanism by which caspases-1/11 promotes
IL-1β release involves GSDM-D, whereas caspase-8 seems to
mediate expression of pro-IL-1β and TNFα. As caspase-8 controls
the release/expression of two key cytokines on Plasmodium-
induced disease, it should be considered a potential target for
therapeutic intervention in malaria patients.
Methods
Ethics statement. The Ethical Committee on Human Experimentation from
Centro de Pesquisas em Medicina Tropical (CEP-CEPEM 096/2009), the Brazilian
National Ethical Committee (CONEP 15653) from Ministry of Health and the
Institutional Review Board from the University of Massachusetts Medical School
(UMMS, IRB-ID11116) approved this study performed with malaria patients.
Experiments with mice were conducted according to institutional guidelines for
animal ethics and approved by the Institutional Ethics Committees from Oswaldo
Cruz Foundation (Fiocruz-Minas, CEUA/LW15/14, and LW16/18) and UMMS
(IACUC/A-2371-15), respectively.
Malaria patients. Healthy donors volunteers (n= 8) from Porto Velho or Belo
Horizonte were used as negative controls. Symptomatic febrile patients with acute
uncomplicated P. vivax (n= 9) and P. falciparum malaria (n= 6) were recruited at
CEPEM, an outpatient malaria clinic in Porto Velho, an endemic malaria area in
the Amazon region of Brazil. Written informed consent was obtained before
enrollment of all subjects. Up to 100 mL of peripheral blood was collected
immediately after confirmation of P. vivax or P. falciparum infection by a standard
thick blood smear. Peripheral blood was also collected from healthy donors living
in an endemic area.
Experimental infections. All mouse lineages used in this study have been back-
crossed for at least ten generations into the C57BL/6 genetic background.
Casp11−/−, Casp1−/−/11tg, and Gsdmd−/− were provided by Dr. Vishva Dixit from
Genentech (San Francisco, CA). Caspase-1−/−/11−/− and Tlr3−/− mice were
provided by Dr. Richard Flavell from Yale University (New Haven, CT). The
Casp1−/− mice were provided by Dr. Devi Kanneganti Thirumala from St. Jude
Children’s Research Hospital (Memphis, TN). Ripk3−/−, Ripk3−/−/Casp8−/−, and
Ripk3−/−/Casp8/1/11−/− were provided by Egil Lien. The Tlr9−/−, Tlr4−/−, and
Tlr7−/− mice were provided by Dr. Shizuo Akira from Osaka University (Osaka,
Japan). The Ripk3−/−/Casp8−/−/Gsdmd−/− and Tlr3/7/9−/− mice were generated
in our laboratory by genetic crosses. The C57BL/6, Ifng−/−, Tnfr−/−, Ifnar1−/−,
and 129S6 were originally obtained from Jackson Labs. All mouse lineages men-
tioned above were bred and maintained in microisolators at Fiocruz-Minas and
UMMS on a 12 h dark/light cycle, temperature range was 68–79 °F, and humidity
between 30 and 70%. Female and male mice between 6 and 10 weeks old were used
in all experiments.
The P. chabaudi chabaudi AS and P. berghei ANKA strains were used for
experimental infection and kept in our laboratory as previously described31,64.
Briefly, P. chabaudi and P. berghei strains were maintained in C57BL/6 mice by
passages once and twice a week, respectively. For experimental infection, wild-type
and various knockout mice were infected i.p. with 105 infected red blood cells
diluted in PBS 1×. In some experiments, mice 0 (uninfected controls) and 8 days
post infection with P. chabaudi were challenged with LPS (serotypes O55:B55 or
0111:B4 from E. coli —Sigma and InvivoGen, respectively) and plasma collected
8 h later. LPS was used at a concentration 10 μg/mouse, as indicated. In
experiments with P. berghei ANKA, mice were followed daily for survival and to
score clinical symptoms. ECM signs included ruffled fur, abnormal postural
responses, reduced reflexes, reduced grip strength, coma, and convulsions. Mice
that demonstrated complete disability in all parameters or died between days 7 and
12 post infection were considered as having ECM31,44.
Human monocyte lysates. PBMCs were isolated from whole blood on Ficoll-
paque Plus (GE Healthcare). Monocytes were purified from PBMCs of P. vivax and
P. falciparum-infected patients or healthy donors by using immunomagnetic beads
for positive selection of CD14+ cells (Miltenyi Biotec). Cells were lysed with RIPA
buffer (Sigma) solution with a protease inhibitor cocktail (ThermoFisher).
Splenocytes and CD11b+ cells. Spleens from control and infected mice were
passed through a 100-μm nylon cell strainer. After the first centrifugation (5 min
400 × g), tissue supernatant was collected. Erythrocytes were then lysed, washed,
and splenocytes resuspended in RPMI 1640 medium supplemented with penicillin,
streptomycin, and 10% fetal bovine serum (FBS) (Gibco, ThermoFisher). In some
experiments, splenocytes (2 × 106 cells) were stimulated in vitro with 1 μg/ml of
LPS for 24–48 h. For experiments with CD11b+ cells purified from splenocytes,
immunomagnetic beads for positive selection of CD11b+ cells (Miltenyi Biotec)
were used.
Bone marrow-derived monocytes (BMDMs). Bone marrow cells from C57BL/6
mice were cultured in DMEM (Corning) with 10% FBS, 10 mM L-glutamine
(Gibco, ThermoFisher), and 20% L929 supernatants. After 7 days 2 × 106 BMDMs
were cultured in 48-wells plate in 300 μl of medium without FBS. The BMDM were
stimulated with 1:5 of red blood cells (RBC) or infected RBCs (iRBC), 40 ng/ml of
IFNγ (Sigma), and 500 U/ml of IFN-I (Pbl Assay Science), as indicated in the figure
legends. Between 16 and 24 h of in vitro stimulation, BMDMs were lysed with
RIPA buffer (Sigma) solution. Culture supernatants were collected, and the soluble
proteins were precipitated using chloroform (25% of supernatant volumes) and
methanol (same supernatant volumes). After centrifugation at 20,000 × g for 10
min at 4 °C, the proteins pellet was dried in 56 °C and suspended in sample buffer.
Western blotting. Total of mouse splenocytes, CD11b+ cells, BMDM, or mono-
cytes from patients were lysed with RIPA buffer solution with a protease inhibitor
cocktail. After 15 min on ice, lysates were centrifuged at 13,000 × g for 10 min at
4 °C. The proteins were separated in a 12%-acrylamide (caspase-11 and caspase-8)
or 4–12% acrylamide (caspase-1/caspase-4/GSDM-D) NUPAGE Bis-tris Protein
gels (Invitrogen) and transferred onto nitrocellulose membranes. The membranes
were incubated with caspase-11 (Novus Biologicals, 1:1000), caspase-1 (Adipogen,
1:1000), caspase-4 (Cell Signaling, 1:1000), anti-mouse and anti-human caspase-8
(Enzo Life Science, 1:1000), anti-mouse cleaved caspase-8 (Cell Signaling, 1:500),
anti-GSDM-D (sigma, 1:1000) and β-actin (Sigma, 1:2000) specific antibodies, then
incubated with HRP-conjugated secondary antibodies (Jackson ImmunoResearch,
1:25,000) and detected with Clarity Max ECL Substrate (Biorad) using ImageLab
Touch Software V6.0.1 (Bio-Rad). Bands quantification was performed with
ImageStudio V5.2. Uncropped western blot is available in the Supplementary
Information file (Supplementary Figs. 5–11).
Cytokine measurements. Measurements of mouse IL-1β and TNFα in plasma or
supernatant of splenocyte cultures were performed using commercially available
ELISA Duoset kit (ThermoFisher). Absorbance was read with SOFTmaxPRO
V4.3.1 LS.
Flow cytometry. Splenocytes (5 × 106 cells) from mice at 0 (uninfected controls)
and 8 days post infection were harvested 2 h after challenge with LPS and stained
with fluorescein-labeled monoclonal antibodies (mAbs) specific for cell surface
markers or cytokines. The following flow cytometry mAbs specific were used:
CD11c-Alexa fluor 700 (1:100), MHC II-APCCy7 (1:200), F4/80- APC (Biolegend,
1:200), CD11b-PECy7 (1:4000), pro-IL-1β-FITC (eBioscience, 1:100), and AmCyan
(Live/Dead kit, ThermoFisher). The intracellular fixation and permeabilization
buffer set of eBioscience (ThermoFisher) were used to perform pro-IL-1β stain.
Cell sorting. Spleens from the C57BL/6 control uninfected and PbA-infected mice,
at 5 days post infection, were harvested, and splenocytes stained with Ly6G (FITC,
1:400) CD11b (PECy7, 1:4000), F4/80 (PECy5, 1:200), CD11c (Alexa fluor 700,
1:100), MHC II (APCCy7, 1:200), and DC-SIGN (APC e-fluor 660, 1:800) and
then submitted to purification by using a cell sorting ARIA (BD). These cells were
first gated on FSC-H/FSC-A, to avoid doublets. Next, we gated on Ly6G−, then
CD11b+F4/80+. Cells from noninfected controls were then gated on MHC II- DC-
SIGN- and from infected mice on MHC IIhigh DC-SIGNhigh. The gated cells were
sorted, collected into fresh new tubes, the MO-DCs were confirmed to be CD11c+
and then used for RNA extraction and RNA-Seq.
RNA-Seq samples and library preparation. RNA-seq was performed in biological
replicates (three mice per group). Monocytes and MO-DCs were purified from
splenocytes using a cell sorting ARIA (BD). Since PbA infection leads to severe
cerebral symptoms and death after the 6th day of infection, MO-DCs (CD11b+F4/
80+CD11c+DC-Sign+MHC II+) were collected from PbA-infected C57BL/6 mice at
day 5 post infection and monocytes (CD11b+F4/80+CD11c−DC-Sign−MHC II−)
collected from noninfected mice. The total RNA was extracted using the Qiagen
RNeasy Mini Kit (Qiagen), and was cleaned and treated with DNase I (Qiagen).
RNA-seq libraries were prepared using the TruSeq Stranded mRNA Kit (ILLUMINA)
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following the manufacturer’s instructions. The total RNA and library quality were
verified by fragmentation analysis (Agilent Technologies 2100 Bioanalyzer) and
submitted for sequencing on the Illumina NextSeq 500 (Bauer Core Facility Harvard
University).
RNA-Seq analysis. Reads previously trimmed with Trimmomatic (Bolger et al.65)
were mapped to the Genome Reference Consortium Mouse Build 38 patch release
5 (GRCm38.p5) using STAR aligner (Dobin et al.66) and the Fragments Per
Kilobase of transcript per million mapped read (FPKM) values and the differential
analysis were calculated with CUFFLINKS (Trapnell et al.67). Genes which were
differentially expressed in response to the infection with fold change ≥ 1.5 were
analyzed for pathway enrichment and network analysis with IPA– Ingenuity
Pathway Analysis from Qiagen (USA); and graphs were done in R statistical
environment, version 3.4.3 (R Core Team, 2019) and Cytoscape software (Shannon
et al.68).
Reagents and softwares. Please see Supplementary Table 1.
Statistical analysis. All data were analyzed using Graphpad Prism V7.0 Software.
The differences between two groups were verified using t test or the
Mann–Whitney test for parametric or nonparametric data, respectively, at 95%
confidence interval (CI). For analysis of multiple groups, we used one-way or two-
way analysis of variance (ANOVA) with additional Bonferroni’s test at 95% CI.
Differences were considered statistically significant when the P < 0.05.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data generated or analyzed during this study are included in this published article
(and its supplementary information files). RNA-seq data are available at the Gene
Expression Omnibus Database, GEO accession number is: GSE126381. All data from this
study are available in figshare with the identifier: https://doi.org/10.6084/m9.
figshare.12751163.v1. Source data are provided with this paper.
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